Multiple Sclerosis Walking Scale (MSWS-12): changes on all items are not equal

被引：0
作者：
Hobart, J. [1 ]
机构：
[1] Peninsula Coll Med & Dent, Plymouth, Devon, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P245
引用
收藏
页码：S92 / S93
页数：2
相关论文
共 50 条
  • [31] Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12
    Motl, Robert W.
    McAuley, Edward
    Mullen, Sean
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 305 (1-2) : 75 - 79
  • [32] Validation of the Multiple Sclerosis Walking Scale-12-Czech version
    Kolcava, J.
    Sladeckova, M.
    Kocica, J.
    Stourac, P.
    Vlckova, E.
    Bednarik, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2021, 84 (04) : 367 - 373
  • [33] Italian Validation of the 12-Item Multiple Sclerosis Walking Scale
    Solaro, C.
    Trabucco, E.
    Signori, A.
    Cella, M.
    Uccelli, M. Messmer
    Brichetto, G.
    Cavalla, P.
    Gironi, M.
    Patti, F.
    Prosperini, L.
    MULTIPLE SCLEROSIS INTERNATIONAL, 2015, 2015
  • [34] The 12-item multiple sclerosis walking scale can detect walking impairment in persons with multiple sclerosis with mild disability
    Kahraman, T.
    Savci, S.
    Ozakbas, S.
    Idiman, E.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (04) : 512 - 512
  • [35] Predicting faller status in persons with multiple sclerosis using the Multiple Sclerosis Walking Scale-12
    Abate, Caterina
    Gromisch, Elizabeth S.
    Campo, Marc
    Ruiz, Jennifer A.
    Delmastro, Heather M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 92
  • [36] ESTIMATION OF THE EFFECT OF DALFAMPRIDINE EXTENDED RELEASE ON HEALTH UTILITY IN PATIENTS WITH MULTIPLE SCLEROSIS USING TWO EQUATIONS FOR MAPPING THE MSWS-12 TO THE EQ-5D
    Limone, B.
    Sidovar, M.
    Gaebler, J. A.
    Lee, S.
    Coleman, C., I
    VALUE IN HEALTH, 2012, 15 (07) : A554 - A555
  • [37] The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D
    Hawton, A.
    Green, C.
    Telford, C. J.
    Wright, D. E.
    Zajicek, J. P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (06) : 853 - 861
  • [38] MEASURING THE IMPACT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS) IN THE ASCEND TRIAL: EQUATING THE MSIS-29, MSWS-12, ABILHAND-56 AND SF-36
    Cano, S.
    Cleanthous, S.
    Marquis, P.
    Hobart, J.
    Naoshy, S.
    Mikol, D.
    Petrillo, J.
    Steiner, D.
    Watson, C.
    VALUE IN HEALTH, 2015, 18 (07) : A713 - A713
  • [39] Predicting fall risk in persons with multiple sclerosis utilizing the 12-item multiple sclerosis walking scale
    Delmastro, H.
    Gromisch, E.
    Dawes, H.
    Deluca, G.
    Krug, R.
    Pick, A.
    Ruiz, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 613 - 613
  • [40] Naturally occurring change in Multiple Sclerosis Walking Scale-12 scores over time in multiple sclerosis
    Motl, Robert W.
    Sandroff, Brian M.
    McAuley, Edward
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2018, 8 (05) : 315 - 322
12345